Wie hoch ist der Preis für Eli Lilly (LLY)

Preis für Eli Lilly (LLY) ist $910.55

Wie hoch ist die Marktkapitalisierung für Eli Lilly (LLY)

Marktkapitalisierung für Eli Lilly (LLY) ist $860.30B

Eli Lilly (LLY) Ausstehende Aktien

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Jahr	Ausstehende Aktien	ändert
2026 (TTM)	898.00M	0.00%
2025	898.00M	-0.29%
2024	900.61M	0.14%
2023	899.38M	-5.35%
2022	950.18M	-0.36%
2021	953.65M	-0.31%
2020	956.59M	-0.10%
2019	957.53M	-6.83%
2018	1.03B	-2.31%
2017	1.05B	-4.44%
2016	1.10B	-0.40%
2015	1.11B	-0.48%
2014	1.11B	-0.55%
2013	1.12B	-2.59%
2012	1.15B	2.92%
2011	1.11B	0.74%
2010	1.11B	0.68%
2009	1.10B	0.35%
2008	1.09B	0.37%
2007	1.09B	0.33%
2006	1.09B	-0.08%
2005	1.09B	0.35%
2004	1.08B	0.74%
2003	1.08B	-0.27%
2002	1.08B	0.12%
2001	1.08B	-0.28%
2000	1.08B	0.00%

Jahr

Ausstehende Aktien

ändert

2026 (TTM)

898.00M

0.00%

2025

898.00M

-0.29%

2024

900.61M

0.14%

2023

899.38M

-5.35%

2022

950.18M

-0.36%

2021

953.65M

-0.31%

2020

956.59M

-0.10%

2019

957.53M

-6.83%

2018

1.03B

-2.31%

2017

1.05B

-4.44%

2016

1.10B

-0.40%

2015

1.11B

-0.48%

2014

1.11B

-0.55%

2013

1.12B

-2.59%

2012

1.15B

2.92%

2011

1.11B

0.74%

2010

1.11B

0.68%

2009

1.10B

0.35%

2008

1.09B

0.37%

2007

1.09B

0.33%

2006

1.09B

-0.08%

2005

1.09B

0.35%

2004

1.08B

0.74%

2003

1.08B

-0.27%

2002

1.08B

0.12%

2001

1.08B

-0.28%

2000

1.08B

0.00%

Unternehmen	Ausstehende Aktien	Unterschied	Land
AstraZeneca PLC AZN.US	3.10B	245.21%	GB
Johnson & Johnson JNJ.US	2.43B	170.44%	US
AbbVie Inc. ABBV.US	1.78B	98.26%	US
Novartis AG NVS.US	1.91B	113.03%	CH
Merck & Co., Inc. MRK.US	2.49B	177.27%	US

Unternehmen

Ausstehende Aktien

Unterschied

Land